Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
16 hedge funds and large institutions have $1.7M invested in Bio-Path Holdings Inc in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
6% less funds holding
Funds holding: 17 → 16 (-1)
24% less capital invested
Capital invested by funds: $2.23M → $1.7M (-$530K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bailard
Foster City,
California
|
+$155K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.3K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$64K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.6K |
| 3 |
BlackRock
New York
|
-$7.96K |
| 4 |
Morgan Stanley
New York
|
-$7.96K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $815K | -$13.6K | -147 | -1% |
|
|
2
BlackRock
New York
| $249K | -$7.96K | -86 | -3% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $248K | – | – | – |
|
|
B
4
Bailard
Foster City,
California
| $126K | +$155K | +1,676 | New |
|
|
5
Morgan Stanley
New York
| $73K | -$7.96K | -86 | -8% |
|
6
Northern Trust
Chicago,
Illinois
| $68K | – | – | – |
|
7
Dimensional Fund Advisors
Austin,
Texas
| $58K | – | – | – |
|
8
State Street
Boston,
Massachusetts
| $46K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $12K | +$11.3K | +122 | +305% |
|
|
10
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | +$1.2K | +13 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$64K | -620 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$7K | -70 | Closed |
|
BPTH Hedge Fund Activity: Q4 2021 in Review
16 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2021, worth a combined $1.7M — down 24% from $2.23M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BPTH and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Bailard, opening a new position worth an estimated $155K. The largest seller was Citadel Advisors, exiting entirely with an estimated $64K sold.
- 16 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2021, down from 17 in Q3 2021.
- Funds reported $1.7M of Bio-Path Holdings Inc stock for Q4 2021, down 24% quarter-over-quarter.
- 2 funds opened new Bio-Path Holdings Inc positions in Q4 2021 and 3 closed out, a net change of -1 holder.
- The largest Bio-Path Holdings Inc buyer in Q4 2021 was Bailard, an estimated $155K added.
- The largest Bio-Path Holdings Inc seller in Q4 2021 was Citadel Advisors, an estimated $64K sold.
Based on aggregated 13F filings for Q4 2021.